| 2016 Canadian Cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in the adult TJ Anderson, J Grégoire, GJ Pearson, AR Barry, P Couture, M Dawes, ... Canadian Journal of Cardiology 32 (11), 1263-1282, 2016 | 1091 | 2016 |
| 2021 Canadian Cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in adults GJ Pearson, G Thanassoulis, TJ Anderson, AR Barry, P Couture, N Dayan, ... Canadian journal of cardiology 37 (8), 1129-1150, 2021 | 727 | 2021 |
| Familial hypercholesterolemia: Review of diagnosis, screening, and treatment RD Turgeon, AR Barry, GJ Pearson Canadian family physician 62 (1), 32-37, 2016 | 110 | 2016 |
| A systematic review of the effect of CYP3A5 genotype on the apparent oral clearance of tacrolimus in renal transplant recipients A Barry, M Levine Therapeutic drug monitoring 32 (6), 708-714, 2010 | 110 | 2010 |
| Assessment of atrial fibrillation patients' education needs from patient and clinician perspectives: a qualitative descriptive study S Salmasi, L Kwan, J MacGillivray, N Bansback, MA De Vera, AR Barry, ... Thrombosis Research 173, 109-116, 2019 | 54 | 2019 |
| Professional use of social media by pharmacists AR Barry, GJ Pearson The Canadian journal of hospital pharmacy 68 (1), 22, 2015 | 53 | 2015 |
| Patients’ perceptions and use of natural health products AR Barry Canadian Pharmacists Journal/Revue Des Pharmaciens Du Canada 151 (4), 254-262, 2018 | 49 | 2018 |
| Pharmacotherapy for heart failure with reduced ejection fraction and health‐related quality of life: a systematic review and meta‐analysis RD Turgeon, AR Barry, NM Hawkins, UM Ellis European Journal of Heart Failure 23 (4), 578-589, 2021 | 46 | 2021 |
| Long‐term beta‐blocker therapy after myocardial infarction in the reperfusion era: a systematic review J Hong, AR Barry Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 38 (5 …, 2018 | 42 | 2018 |
| Omega-3 polyunsaturated fatty acid supplementation in the prevention of cardiovascular disease CP Walz, AR Barry, SL Koshman Canadian Pharmacists Journal/Revue des Pharmaciens du Canada 149 (3), 166-173, 2016 | 42 | 2016 |
| Case report and review of clenbuterol cardiac toxicity AR Barry, MM Graham Journal of Cardiology Cases 8 (4), 131-133, 2013 | 34 | 2013 |
| Adverse drug reactions: The importance of maintaining pharmacovigilance AR Barry, SL Koshman, GJ Pearson Canadian Pharmacists Journal/Revue des Pharmaciens du Canada 147 (4), 233-238, 2014 | 33 | 2014 |
| An evaluation of teaching physical examination to pharmacists AR Barry, L McCarthy, CL Nelson, GJ Pearson Canadian Pharmacists Journal/Revue des Pharmaciens du Canada 145 (4), 174 …, 2012 | 33 | 2012 |
| Prevention and management of statin adverse effects: A practical approach for pharmacists AR Barry, JE Beach, GJ Pearson Canadian Pharmacists Journal/Revue des Pharmaciens du Canada 151 (3), 179-188, 2018 | 32 | 2018 |
| Primary prevention of cardiovascular disease in older adults AR Barry, DE O'Neill, MM Graham Canadian Journal of Cardiology 32 (9), 1074-1081, 2016 | 32 | 2016 |
| Pharmacotherapy of heart failure with preserved ejection fraction JE Basaraba, AR Barry Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 35 (4 …, 2015 | 32 | 2015 |
| Influenza vaccination for secondary prevention of cardiovascular events: a systematic review MH LeBras, AR Barry The Canadian Journal of Hospital Pharmacy 70 (1), 27, 2017 | 29 | 2017 |
| Longitudinal oral anticoagulant adherence trajectories in patients with atrial fibrillation S Salmasi, MA De Vera, A Safari, LD Lynd, M Koehoorn, AR Barry, ... Journal of the American College of Cardiology 78 (24), 2395-2404, 2021 | 27 | 2021 |
| Effect of glucagon-like peptide-1 receptor agonists on all-cause mortality and cardiovascular outcomes: a meta-analysis SC Peterson, AR Barry Current Diabetes Reviews 14 (3), 273-279, 2018 | 27 | 2018 |
| A systematic review of add-on pharmacologic therapy in the treatment of resistant hypertension AP Tataru, AR Barry American Journal of Cardiovascular Drugs 17, 311-318, 2017 | 26 | 2017 |